The Effectiveness of Transurethral Resection of the Prostate Combined with High Power Potassium-titanyl-phosphate (KTP) Laser Vaporization for Patients with a Prostate Volume Greater than 45cc

Purpose: We compared the effectiveness of transurethral resection of the prostate (TURP) with the effectiveness of high power potassium-titanylphosphate (KTP) laser vaporization combined with TURP in patients with a prostate volume over 45cc. Materials and Methods: Between March 2004 and March 2007, we analyzed all the patients with a prostate volume over 45cc and who underwent TURP or KTP laser vaporization combined with TURP for treating symptomatic benign prostatic hyperplasia (BPH). The patients were divided into two groups (Group I: TURP: n=53, Group II: KTP laser vaporization combined with TURP: n=54). The initial evaluation included a digital rectal examination, urinalysis, determining the hemoglobin, electrolyte and prostate-specific antigen (PSA) levels, the International Prostate Symptom Score (IPSS), the quality of life (QoL), the maximum urine flow rate (Qmax), the postvoiding residual urine (PVR), transrectal ultrasonography (TRUS) and urodynamic study. The postoperative hemoglobin and electrolyte levels were checked promptly, and the total operation time, the foley indwelling period and the number of hospital days were recorded afterwards. The IPSS, QoL, Qmax, and PVR were evaluated at 1 and 3 months postoperatively. Results: The baseline characteristics and postoperative outcomes of the two groups were similar. The total blood loss during operation was significantly lower in Group II (p=0.02). Conclusions: KTP laser vaporization combined with TURP resulted in less blood loss than TURP and it provided a good operation field in those patients who have over 45cc of prostate. Thus, KTP laser vaporization combined with TURP is safer than performing only TURP. (Korean J Urol 2008;49:1007-1012) 󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏

[1]  K. Sarıca,et al.  Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. , 2008, Urology.

[2]  Scott Van Appledorn,et al.  KTP laser versus transurethral resection: early results of a randomized trial. , 2006, Journal of endourology.

[3]  D. M. Barrett,et al.  Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. , 2005, The Journal of urology.

[4]  Harbans Singh,et al.  Bipolar versus monopolar transurethral resection of prostate: randomized controlled study. , 2005, Journal of endourology.

[5]  U. Treiber,et al.  [Transurethral resection for benign prostatic hyperplasia. current developments]. , 2005, Der Urologe. Ausg. A.

[6]  R. Hartung,et al.  Transurethrale Resektion bei benigner Prostatahyperplasie , 2005, Der Urologe, Ausgabe A.

[7]  S. Kaplan,et al.  High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. , 2004, Urology.

[8]  F. Gu.  Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China. , 2000, Chinese medical journal.

[9]  J. Roberts,et al.  Immediate and postoperative complications of transurethral prostatectomy in the 1990s. , 1999, The Journal of urology.

[10]  R C Bruskewitz,et al.  Recent developments in the surgical management of benign prostatic hyperplasia. , 1998, Urology.

[11]  C. Roehrborn.  Meta-analysis of randomized clinical trials of finasteride. , 1998, Urology.

[12]  M. Barry,et al.  Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes. Prostate Patient Outcomes Research Team (PORT). , 1994, Urology.

[13]  R. Barnes,et al.  Forty years of transurethral prostatic resections. , 1976, The Journal of urology.

[14]  M. Reuter,et al.  [Combined treatment of prostatic adenoma with the 80 Watt KTP-laser and low-pressure transurethral resection]. , 2006, Actas Urológicas Españolas.

[15]  A. B. Verger-Kuhnke,et al.  Tratamiento combinado del adenoma prostático con el KPT-láser de 80 Watt y la resección transuretral de baja presión , 2006 .

[16]  Xu Zi-li.  Transurethral resection of benign prostatic hyperplasia , 2005 .

[17]  H. L. Holtgrewe,et al.  Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol, 141: 243-247, 1989. , 2002, The Journal of urology.

[18]  M. Barry,et al.  Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes. Prostate Patient Outcomes Research Team (PORT). , 1994, Urology.